✨ Medicines Schedule
2250 NEW ZEALAND GAZETTE No. 94
Schedule
Product: Lescol.
Active Ingredient(s): Fluvastatin sodium 21.06 mg equivalent to 20 mg fluvastatin.
Dosage Form: Capsule.
NZ Sponsor: Novartis New Zealand Limited.
Manufacturer(s): Novartis Farmaceutica S.A., Barbera del Valles, Barcelona, Spain.
Product: Lescol.
Active Ingredient(s): Fluvastatin sodium 42.12 mg equivalent to 40 mg fluvastatin.
Dosage Form: Capsule.
NZ Sponsor: Novartis New Zealand Limited.
Manufacturer(s): Novartis Farmaceutica S.A., Barbera del Valles, Barcelona, Spain.
Product: Plendil ER.
Active Ingredient(s): Felodipine 10 mg.
Dosage Form: Modified release tablet.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): Astra Pharmaceutical Production AB, Sodertalje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.
Product: Plendil ER.
Active Ingredient(s): Felodipine 2.5 mg.
Dosage Form: Modified release tablet.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): Astra Pharmaceutical Production AB, Sodertalje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.
Product: Plendil ER.
Active Ingredient(s): Felodipine 5 mg.
Dosage Form: Modified release tablet.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): Astra Pharmaceutical Production AB, Sodertalje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.
Product: Prograf.
Active Ingredient(s): Tacrolimus 1 mg.
Dosage Form: Capsule.
NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): Fujisawa Ireland Limited, Killorglin, Co Kerry, Eire.
Product: Prograf.
Active Ingredient(s): Tacrolimus 5 mg.
Dosage Form: Capsule.
NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): Fujisawa Ireland Limited, Killorglin, Co Kerry, Eire.
Product: Prograf.
Active Ingredient(s): Tacrolimus 5 mg/mL.
Dosage Form: Solution for infusion.
NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): Fujisawa Ireland Limited, Killorglin, Co Kerry, Eire.
Dated this 9th day of August 1999.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5853
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 94
NZLII —
NZ Gazette 1999, No 94
✨ LLM interpretation of page content
🏥
Consent to the Distribution of Changed Medicines
(continued from previous page)
🏥 Health & Social Welfare9 August 1999
Medicines, Distribution, Consent, Medicines Act 1981
- G. R. Boyd, Chief Advisor, Safety and Regulation